John Leonard, President and CEO of Intellia Therapeutics, discussed the Phase 3 results for Lonvo-Z.
2 reports, 2 independent
Updated Sep 9
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
John Leonard, President and CEO of Intellia Therapeutics, discussed the Phase 3 results for Lonvo-Z.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Keep exploring
The entities involved
-
John Leonard
Nothing else this week.